Alembic Pharmaceuticals Limited has informed the Exchange about change in Management - Appointment of Chief Financial Officer of the Company

Management Changes View source PDF Explain this filing

APLLTD · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+0.5%Reaction day

₹996.20

prior close

₹1003.20

announcement price

In-mkt

timing

Nifty Microcap 250market · index membership as recorded later (tracked since Jun 2026)-0.5%+1.0% vs market

Pharmaceuticals peers, median of 150sector-0.4%+0.9% vs sector

On the reaction day the stock moved 1.0 pts more than Nifty Microcap 250 and 0.9 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+0.1

10m

+0.3

15m

+0.0

30m

+0.2

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+0.5-0.5+1.0-0.4+0.9

Next day

+0.4-0.6+1.0-1.0+1.4

-1.1-0.1-1.0-0.6-0.5

-1.6+0.3-1.9-0.9-0.7

-2.0-0.2-1.8-1.1-0.9

+2.9-0.1+3.0-0.3+3.2

+2.9+1.6+1.3+1.1+1.8

15d

+0.7-2.5+3.2-1.6+2.3

-4.9-4.2-0.7-4.9+0.0

-5.3-2.6-2.7-4.5-0.8

-7.8-3.7-4.0-5.4-2.4

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 150Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Alembic Pharmaceuticals has appointed Mr. G. Krishnan as its new Chief Financial Officer and Key Managerial Personnel, effective 7th July 2025. Mr. Krishnan brings over 22 years of experience across pharmaceuticals, life sciences, telecom, and the social sector. He is a qualified Chartered Accountant, Company Secretary, and Cost & Management Accountant. Prior to this role, he served as Vice President and CFO of Syngene Scientific Solutions Limited (a Syngene International subsidiary) since May 2020, and earlier held leadership positions at Vodafone and Tata Trusts. His expertise spans business finance, mergers and acquisitions, governance, risk management, and scalable finance systems.

Likely market impact

This is a senior leadership change that brings an experienced external finance professional into the company. For shareholders, the appointment signals a focus on strengthening financial governance and strategic planning, though the near-term stock impact is likely to be neutral unless further context on the previous CFO's departure is provided.